World premiere of the new Rx
World premiere of the new Rx at ESCRS 2026
𝟭𝟭–𝟭𝟱 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟲 at 𝗘𝘅c𝗲𝗟 𝗟𝗼𝗻𝗱𝗼𝗻, 𝗨𝗞.
First capsulorhexis-fixated IOL implantation with Rx femtosecond laser platform
First capsulorhexis-fixated with Teleon IOL : Femtis
Interviews of Helix Surgical team members
Helix team members interviews
Helix Surgical Appoints Florent Deloison as CEO
Helix Surgical Appoints Florent Deloison as President and CEO to Lead the Commercial Launch Phase of the Rx Femtolaser
Helix Surgical wins the prestigious SPIE Prism Awards 2026
Home News Helix Surgical winner of the 2026 SPIE Prism Awards ! We are proud to announce that Helix Surgical won the 2026 SPIE Prism Awards. This recognition places us alongside some of the most innovative technologies shaping the future of photonics and medical innovation. Being awarded this prestigious international award reinforces our commitment to pushing […]
ESCRS 2025 – Booth #E218
We are excited to announce our participation at the ESCRS Congress 2025 in Copenhaguen! Booth #E218
“As fast as Manual patient flow”
Dr Lignereux compared capsulotomy method’s impacts on patient flow. The 3rd Gen Handheld femto is a game changer.
Rx clinical trial results
Dr. Lignereux, Institut Ophtalmologique Sourdille Atlantique, Nantes, France, participated in the clinical trial from February 2022 to March 2023.
ASCRS 2024 – Come and meet us – Booth#1349
An other exciting event for Helix Surgical. The ASCRS (American Society of Cataract and Refractive surgery) Congress (April 5-8, 2024) is a major event in the field of ophthalmologic surgery, providing a valuable platform to learn about the latest progress and surgical techniques.
Rx is now CE marked ! Rx just received MDR clearance.
December 12th, 2023 – We are delighted to announce a significant milestone at Helix Surgical. Our Rx has achieved CE marking.